Darrell J. Elliott

SMC Ventures, Inc. engaged in the provision of management consulting services. The company was founded in 1980 and is headquartered in Vancouver, Canada.

Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada.

Inex Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer.

Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology

ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada.

IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland.

IsoTis, Inc. designs, manufactures and sells bone graft substitutes and other devices. The company was founded on November 15, 2006 and is headquartered in Plainsboro, NJ.

Auricle Biomedical Corporation is a capital pool company, formed to acquire, through amalgamation, merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more domestic or foreign operating businesses in the healthcare industry. The company proposes to identify and evaluate businesses and assets with a view to completing a qualifying transaction. The company was founded on June 1, 2007 and is headquartered in Vancouver, Canada.

RBC Capital Partners Ltd. is a Venture Capital firm, a subsidiary of RBC Dominion Securities, Inc. founded in 1900. RBC Capital Partners Ltd. is headquartered in Toronto, Canada with offices across the globe.

Aztech Innovations, Inc. is engaged in the sale of embedded systems, wireless remote monitoring and demand management products and related services. It was founded on March 7, 2007 and is headquartered in Kingston, Canada.

North American Healthcare International, Inc. provides healthcare and related professional services. The company is headquartered in Calgary, Canada.

Jana Care, Inc. develops a mobile diagnostic platform to screen for and monitor chronic diseases. It offers The Aina Device, a self-monitoring device for use by patients at home; and The Aina Station, a point-of-care diagnostic solution for use in clinics and hospitals. The company was founded by Sidhant Jena and Michal Depa in 2011 and is headquartered in Boston, MA.